adductor spasmodic dysphonia


Also found in: Acronyms.

adductor spasmodic dysphonia

a form of spasmodic dysphonia in which excessive closure of the vocal folds affects the initiation and maintenance of phonation.

ad·duc·tor spas·mod·ic dys·pho·nia

(ă-dŭk'tŏr spaz-mod'ik dis-fō'nē-ă)
A form of spasmodic dysphonia in which excessive closure of the vocal cords affects the initiation and maintenance of phonation.
Mentioned in ?
References in periodicals archive ?
Chhetri et al., "Long-Term Follow-Up Results of Selective Laryngeal Adductor Denervation-Reinnervation Surgery for Adductor Spasmodic Dysphonia," The Laryngoscope 116, no.
Berke, "Treatment of Adductor Spasmodic Dysphonia with Selective Laryngeal Adductor Denervation and Reinnervation Surgery," Otolaryngologic Clinics of North America 39, no.
(65.) Chhetri and Berke, "Adductor Spasmodic Dysphonia"; Abie H.
Radiofrequency thyroarytenoid myothermy for treatment of adductor spasmodic dysphonia: how we do it.
Lidocaine block of the recurrent laryngeal nerve in adductor spasmodic dysphonia: a multidimensional assessment.
Longitudinal follow-up of adductor spasmodic dysphonia patients after botulinum toxin injection: quality of life results.
Relationship of botulinum dosage to duration of side effects and normal voice in adductor spasmodic dysphonia. Otolaryngol Head Neck Surg.
Long-term botulinum toxin dose consistency for treatment of adductor spasmodic dysphonia. Ann Otol Rhinol Laryngol 2007; 116:891-6.
Injections can be administered unilaterally or bilaterally in patients with adductor spasmodic dysphonia, although there is some controversy over the efficacy and degree of side effects with the two techniques.
As is the case with patients who have adductor spasmodic dysphonia, results in patients with abductor spasmodic dysphonia vary, but many do obtain benefit from botulinum toxin injections.
Effects of botulinum toxin therapy in patients with adductor spasmodic dysphonia: Acoustic, aerodynamic, and videoendoscopic findings.
A comparison of the efficacy of unilateral versus bilateral botulinum toxin injections in the treatment of adductor spasmodic dysphonia. J Otolaryngol 1994;23:160-4.